| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Gemcitabine-induced activation of checkpoint signaling pathways that affect tumor cell survival. | Mol Pharmacol | 2005 | 1.61 |
| 2 | Rationale for folate receptor alpha targeted therapy in "high risk" endometrial carcinomas. | Int J Cancer | 2008 | 0.86 |
| 3 | Polyostotic fibrous dysplasia mimicking bone metastases in a patient with advanced-stage cervical cancer. | Gynecol Oncol | 2009 | 0.75 |
| 4 | Surgical-pathologic risk factors and immunohistochemical markers of pelvic lymph node metastasis in stage IB1 cervical cancer. | J Low Genit Tract Dis | 2011 | 0.75 |
| 5 | Methotrexate on a 21-day cycle for low-risk gestational trophoblastic neoplasia. | J Reprod Med | 2012 | 0.75 |
| 6 | Peri-operative management of heparin-induced thrombocytopenia syndrome in a patient with a suspected gynecologic malignancy. | Semin Oncol | 2015 | 0.75 |